Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

Squaric acid dibutylester led to complete hair regrowth in 28.5% of patients with alopecia areata.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Topical immunotherapy is the best treatment for severe alopecia areata.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Unani medicine helped regrow eyebrow hair in 45 days.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.